期刊文献+

环境污染物As及SHP2D61G/+激活对小鼠成纤维母细胞miRNA表达谱的影响 被引量:3

Effect of environmental pollutant-As and SHP2^(D61G/+) activation on miRNA expression profiles in MEFs
下载PDF
导出
摘要 目的建立环境致癌物与基因突变联合因素影响下的miRNA表达谱,为肿瘤发生机制的进一步研究提供新线索。方法同等条件下,首先制备SHP2+/+野生型(wild type,Wt)及SHP2D61G/+激活突变(gain-of-function mutation,GOF mutation)小鼠永生化的成纤维母细胞(mouse embryonic fibroblasts,MEFs)细胞,之后以0.5μmol/L的三氧化二砷急性处理MEFs细胞48 h后提取细胞总RNA,用小鼠miRNA芯片杂交/分析,建立miRNA(microRNA,miRNA,miR)表达谱,筛选差异表达显著者,用RT-PCR进行验证。结果重金属化合物三氧化二砷处理SHP2+/+野生型和SHP2D61G/+突变的MEFs细胞48h后,数十个miRNAs出现差异性表达,miRNA在三氧化二砷诱导前后的细胞或SHP2激活突变与否的细胞出现表达增加或减少,且发现受三氧化二砷和SHP2激活突变影响变化一致的miRNAs,如mmu-miR-100(表达下降)、mmu-miR-1907(表达升高)等,RT-PCR检测发现mmu-miRNA-100、mmu-miRNA-1907的表达趋势与芯片结果是一致的。结论基因突变与环境污染可以影响MEFs细胞的miRNA表达谱出现明显改变,这些改变可能是细胞恶性转化及肿瘤发生的基础。 Objective Establish the miRNA expression profiling under environmental carcinogens and gene mutations, to provide some new clues for further study on the mechanism of tumorgencsis. Methods Under the same condition, mice were first prepared in SHP2 ^+/+ normal (wild type, Wt)and SHP2^D61G/+ activating mutation (gain-of- function mutation, GOF mutation)of immortalized fibroblast cells( mouse embryonic fibroblasts, MEFs), acute treat MEFs cells with 0. 5μLmoL/L As2 03 48 hours, then extract the cell total RNA. Use the analysis of miRNA hybridization to establish the miRNA (microRNA, miRNA, miR)expression profiling, screening the miRNAs which differential expressionsignificantly, then validated by RT-PCR. Results After treated the SHP2 ^+/+ MEFs and SHP2^D61G/+ MEFs with As203, dozens of miRNAs showed differential expression. The expression of miRNAs increase or decrease in different SHP-2^ +/+ MEFs or SHP-2^D61G/+ MEFs when treat with As203 or not, at the same time, we discovered some miRNAs show the same change along with the As203 treating and SHP2^D61G/+ activating mutation, such as mmu-miRNA-100 (down regulation) and mmu-miRNA-1907( np regulation). Conclusion Gene mutation and environmental pollution can effect the miRNAs expression profiling of MEFs significantly, these change maybe the basis of cells malignant transformation and tumourgenesis.
出处 《中国比较医学杂志》 CAS 2013年第7期1-6,共6页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金(编号:81272258) 安徽省留学回国人员科研项目(编号:2009-2011) 安徽省学科学术带头人基金
关键词 SHP2 环境污染 基因突变 肿瘤 SHP-2 miRNA Environmental pollution Mutation Tumor
  • 相关文献

参考文献19

  • 1重金属污染综合防治分析.中国投资研究网.2012[2012-09-14].http://baike.baidu.com/view/282970.htm.
  • 2Veuger Stephany J.,Durkacz Barbara W.Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation[J].Discover Ref doc,2011,10(2):235-244.
  • 3Siying Wang,Wen-Mei Yu,Wanming Zhang,et al.Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis[J].J.Biol.Chem.,2009,284(2):913-920.
  • 4Zhong-Qing Shi,Carmen R.Sunico,et al.Lipton S-nitrosylated SHP-2 contributes to NMDA receptor-mediated excitotoxicity in acute ischemic stroke[J].PNAS,2013,110 (8):3137-3142.
  • 5Dan Xu,Siying Wang,Wen-Mei Yu,et al.A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells[J].Blood,2010,116(18):3611-3621.
  • 6Grossmann KS.The tyrosine phosphatase Shp2 in development and cancer[J].Cancer Res,2010,106:53-89.
  • 7Bouyain S,Watkins DJ.Identification of tyrosine phosphatase ligands for cont-actin cell adhesion molecules[J].Commune Integer Biol 2010,3(3):284-286,.
  • 8Serra V,Scaltriti,L Prudkin,et al.PI3K inhibition results in enhanced HER Signaling and acquired ERK dependency in HER2-over-expressing breast cancer[J].Oncogene,2011,30,2547-2557.
  • 9王海林,刘嘉琳,宗园媛,张连峰,秦川.Mir-106b对阿尔茨海默病昼夜节律调控的初步研究[J].中国比较医学杂志,2010,20(4):19-23. 被引量:4
  • 10David P.Bartel.MicroRNAs:Target Recognition and Regulatory Functions[J].Cell.,2009,136,(2):215-233.

二级参考文献26

  • 1Leikowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization[ J]. J Biol Chem, 1998, 273:18677 - 18680.
  • 2Pitcher JA, Freedman N J, Leikowitz BJ. G protein-coupled receptor kinases [JJ. Annu Rev Biochem, 1998, 67:653 - 692.
  • 3Carman CV, Som T, Kim CM, et al. Binding and phosphorylation of tubulin by G protein-coupled receptor kinases [J]. J BiolChem, 1998, 273(32) :20308 -20316.
  • 4Pronin AN, Morris AJ, Surguchov A, et al. Synucleins are a novel class of substrates for G protein-coupled receptor kinases [J]. J Biol Chem, 2000, 275(34):26515 -26522.
  • 5Freeman JL, Gonzalo P, Pitcher JA, et al. Beta 2-adrenergic receptor stimulated, G protein-coupled receptor kinase 2 mediated phosphorylation of ribosomal protein P2 [J].Biochemistry, 2002, 41 (42) : 12850 - 12857.
  • 6Pitcher JA, Fredefieks ZL, Stone WC, et al. Phosphatidylinositol 4, 5-bisphosphate ( PIP2 )-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies [ J ]. J Biol Chem, 1996, 271:24907 - 24913.
  • 7Pronin AN, Carman CV, Benovic JL. Structure-function analysis of G protein-coupled receptor kinase-5 [ J]. J Biol Chem, 1998, 273:31510 - 31518.
  • 8Levay K, Satpaev DK, Pronin AN, et al. Localization of the sites for Ca2^+ -binding proteins on G protein-coupled receptor kinases [J]. Biochemistry 1998, 37:13650 - 13659.
  • 9Johnson LR, Scott MG, Pitcher JA. G protein-coupled receptor kinase .5 contains a DNA-binding nuclear localization sequence [J]. Mol CellBiol, 2004, 24:10169 -10179.
  • 10Arawaka S, Wada M, Goto S, et al. The role of G-proteincoupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease[ J]. J Neurosci, 2006, 26:9227 - 9238.

共引文献3

同被引文献20

  • 1Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs [J]. Cell, 2009,136(4):642-655.
  • 2Bushati N, Cohen SM. microRNA functions [J]. Annu Rev Cell Dev Biol, 2007,23 : 175-205.
  • 3Sun J, Chen Z, Tan X, et al. MicroRNA-99a/100 promotes ap- optosis by targeting roTOR in human esophageal squamous cell car-cinoma [J]. Medical oncology, 2013,30( 1 ) :411-420.
  • 4Kolokythas A, Miloro M, Zhou X. Review of microRNA deregula- tion in oral cancer. Part I [J]. J Oral Maxillofac Res, 2011,2 (2) :1-35.
  • 5Nagaraja AK, Creighton CJ, Yu Z, et al. A link between miR- 100 and frapl/mtor in clear cell ovarian cancer [ J ]. Mol Endncri- nol, 2010,24(2) :447-463.
  • 6Ton'es A, Torres K, Pesci A, et al. Deregulation of miR-100, miR-99a and miR-1998 in tissues and plasma coexists with in- creased expression of mTOR kinase ill endometrioid endometrial carcinoma [ J ]. BMC Cancer, 2012,12:369-382.
  • 7Wang S, Xue S, Dai Y, et al. Reduced expression of microRNA- 100 confers unfavorable prognosis in patients with bladder cancer [ J ]. Diagn Pathol, 2012,7 : 159-166.
  • 8Chen P, Zhao X, Ma L. Down regulation of miR-100 correlates with tumor progression and poor prognosis in hepatocellular carci- noma [J]. Mol Cell Biochem, 2013,383(I-2) :49-58.
  • 9Liu J, Lu KH, Liu ZL, et al. MicroRNA-100 is a potential molec- ular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinasel [ J ]. BMC cancer, 2012,12:519-530.
  • 10Luo D, Wilson JM, Harve N, et al. A systematic evaluation of miRNA-mRNA interactions involved in the migration and invasion of breast cancer cells [J]. J Transl Med, 2013,11:57-71.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部